Article
Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.
European journal of cancer (Oxford, England : 1990) - 1 Dec 2017
Verlingue Loic, Malka David, Allorant Adrien, Massard Christophe, Ferté Charles, Lacroix Ludovic, Rouleau Etienne, Auger Nathalie, Ngo Maud, Nicotra Claudio, De Baere Thierry, Tselikas Lambros, Ba Bakar, Michiels Stefan, Scoazec Jean-Yves, Boige Valérie, Ducreux Michel, Soria Jean-Charles, Hollebecque Antoine
Abstract excerpt
BACKGROUND: Recommended treatments of patients with advanced biliary tract cancer (aBTC) are limited to one chemotherapy doublet. Nevertheless, efficacy of treatment personalisation for aBTCs is supported by accumulating evidences but remains to be evaluated. PATIENTS AND METHODS: Patients with aBTCs included in the prospective clinical trial MOSCATO-01 were treated by at least one previous systemic treatment,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
